Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese approval for St Jude's Genesis pain relief device

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved St Jude Medical's Genesis neurostimulation system. It is now available in Japan for the management of chronic pain of the limbs and trunk, including that caused by failed back surgeries. Genesis is a small implanted device that delivers mild electrical pulses via leads placed near the spinal cord, which are thought to interrupt pain signals to the brain. The device is also approved in the US, Canada, Australia, certain Latin American and Asian markets, including China, and is CE marked for sale in Europe. It is similar to the St Paul, Minnesota company's Eon and Eon Mini neurostimulators but, unlike them, is not rechargeable.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045254

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel